**Core Concept**
Pseudomembranous enterocolitis is a condition characterized by inflammation of the colon and small intestine, often caused by antibiotic-associated disruption of the gut microbiota. Metronidazole is a nitroimidazole antibiotic that targets anaerobic bacteria, including Clostridioides difficile (C. diff), the primary cause of antibiotic-associated pseudomembranous enterocolitis.

**Why the Correct Answer is Right**
Metronidazole exerts its antibacterial effects by entering anaerobic bacteria and generating free radicals that damage DNA, ultimately leading to bacterial cell death. This mechanism is particularly effective against C. diff, which thrives in low-oxygen environments. Metronidazole is also a key component of triple therapy regimens for the eradication of Helicobacter pylori (H. pylori), a bacterium that causes peptic ulcers and gastric cancer. The combination of metronidazole, a proton pump inhibitor (PPI), and a clarithromycin or amoxicillin is used to target H. pylori and prevent recurrence.

**Why Each Wrong Option is Incorrect**
**Option A:** Amoxicillin is a beta-lactam antibiotic that targets a broad spectrum of bacteria, but it is not the primary choice for treating pseudomembranous enterocolitis or H. pylori infection.
**Option B:** Vancomycin is a glycopeptide antibiotic that is effective against Gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA). However, it is not the preferred treatment for pseudomembranous enterocolitis or H. pylori infection.
**Option D:** Clotrimazole is an antifungal agent that is used to treat a variety of fungal infections, but it is not effective against bacterial infections such as pseudomembranous enterocolitis or H. pylori.

**Clinical Pearl / High-Yield Fact**
Remember that metronidazole is a key component of the treatment for C. diff infection and H. pylori eradication. However, it can cause side effects such as nausea, diarrhea, and neurological toxicity at high doses.

**✓ Correct Answer: C. Metronidazole**